The pharmacokinetics, pharmacodynamics, and tolerability of liraglutide, a once-daily human GLP-1 analogue, after multiple subcutaneous administration in healthy Chinese male subjects
Even moderate doses (8 mg) led to ~2223% weight loss, highlighting a dose-responsive effect
However, if one needs reductions in both fasting and postprandial glucose levels a longer acting agent such as repaglinide is a better choice
[DOI] [PMC free article] [PubMed] [Google Scholar] 80.Cortes TM, Vasquez L, Serra MC, Robbins R, Stepanenko A, Brown K, Barrus H, Campos A, Espinoza SE, Musi N
The dosing is completely different between the two medications and it does not translate between them
If you're currently on a prescription GLP-1 injection and you're thinking about switching, please speak to your healthcare provider first